DERM – journey medical corporation (US:NASDAQ)

News

Despite Journey Medical's Pullback, Insiders Still Gained US$118k [Yahoo! Finance]
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com